Clinical Trial Update: Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether alpha-lipoic acid reduces pain and side effects during concurrent treatment of head and neck squamous cell carcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of Colorado, Denver | Conditions: HNSCC | Phase 1 | Status: COMPLETED